Finance
Medwave closes on $1.75 million of additional capital
Published in Medical Devices and Surgical Technology Week, March 2nd, 2003
The terms of the financing included the sale of 1.4 million shares of common stock at a price of $1.25 per share; no stock warrants or other securities were issued. The company completed this financing without the use of an investment-banking firm, saving the company considerable expense.
Anchoring the financing was Heartland Advisors of Milwaukee, Wisconsin. Heartland purchased 800,000 shares of Medwave stock for their Heartland Value Fund, (HRTVX).
Other...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Breast Cancer
Breathing device may help spare normal tissue from radiation side effects - Tissue Hypoperfusion
Sublingual system first to measure carbon dioxide - Cervical Cancer
Standardizing the measurement of the value of health care interventions - Clinical Trials
First report using subject ignorance, sham intervention published in 1784 - Diagnostics
HHS approves widespread use of new 20-minute HIV test - Infectious Disease
Novel mass spectrometry-based test reveals sulfated metabolites - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
